SCHEMBL4914715

SCHEMBL4914715

Cc1nc(Nc2cccc3cccnc23)sc1C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.48
LMNA P02545 1/20 0.48
MAPK10 P53779 1/20 0.48
RXFP1 Q9HBX9 1/20 0.48
POLB P06746 3/20 0.48
TDP1 Q9NUW8 1/20 0.48
MAPT P10636 7/20 0.47
KMT2A Q03164 4/20 0.47
KDM4E B2RXH2 4/20 0.47
MEN1 O00255 3/20 0.47
HTT P42858 2/20 0.47
NPSR1 Q6W5P4 1/20 0.47
KDR P35968 2/20 0.47
NPC1 O15118 6/20 0.46
HDAC6 Q9UBN7 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
RAB9A P51151 5/20 0.45
HPGD P15428 2/20 0.45
RECQL P46063 1/20 0.45
CASP3 P42574 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5360243 0.85 HDAC6 (0.49) ALDH1A1POLBTDP1MAPTKMT2A
SCHEMBL4914698 0.81 KMT2A (0.53) ALDH1A1LMNAPOLBTDP1MAPT
SCHEMBL4923629 0.79 MAPT (0.56) ALDH1A1LMNAPOLBMAPTKMT2A
SCHEMBL27957021 0.76 MAPT (0.54) ALDH1A1LMNAMAPK10RXFP1POLB
SCHEMBL4924626 0.74 MAPT (0.76) ALDH1A1LMNAMAPTKMT2AKDM4E
SCHEMBL4765972 0.74 NPC1 (0.76) ALDH1A1LMNAPOLBMAPTKMT2A
SCHEMBL347316 0.72 SMN1; SMN2 (0.52) ALDH1A1LMNAPOLBTDP1MAPT
SCHEMBL347317 0.72 SMN1; SMN2 (0.52) ALDH1A1LMNAPOLBTDP1MAPT
SCHEMBL5363055 0.72 EGLN1 (0.51) ALDH1A1TDP1MAPTKMT2AKDM4E
SCHEMBL1695444 0.72 KDR (0.71) ALDH1A1POLBTDP1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family DEVGEN NV (BE) 2008-05-29 US claimed
EP-1819330-A1 5-CARBOXAMIDO SUBSTITUED THIAZOLE DERIVATIVES THAT INTERACT WITH ION CHANNELS, IN PARTICULAR WITH ION CHANNELS FROM THE KV FAMILY Devgen N.V. (BE) 2007-08-22 EP claimed
WO-2006058905-A1 5-CARBOXAMIDO SUBSTITUTED THIAZOLE DERIVATIVES THAT INTERACT WITH ION CHANNELS, IN PARTICULAR WITH ION CHANNELS FROM THE Kv FAMILY DEVGEN NV (BE) 2006-06-08 WO claimed
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family DEVGEN NV (BE) 2008-05-29 US disclosed
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family DEVGEN NV (BE) 2008-05-29 US disclosed
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family DEVGEN NV (BE) 2008-05-29 US disclosed
EP-1819330-A1 5-CARBOXAMIDO SUBSTITUED THIAZOLE DERIVATIVES THAT INTERACT WITH ION CHANNELS, IN PARTICULAR WITH ION CHANNELS FROM THE KV FAMILY Devgen N.V. (BE) 2007-08-22 EP disclosed
WO-2006058905-A1 5-CARBOXAMIDO SUBSTITUTED THIAZOLE DERIVATIVES THAT INTERACT WITH ION CHANNELS, IN PARTICULAR WITH ION CHANNELS FROM THE Kv FAMILY DEVGEN NV (BE) 2006-06-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family KCNA5, KCNA1, KCNJ2 ALDH1A1 1395/4885LMNA 2199/4885MAPK10 1762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.